Tekla Life Sciences Investors Paid Distribution
31 Dezember 2021 - 4:21PM
Business Wire
On December 31, 2021, Tekla Life Sciences Investors paid a
distribution of $0.42 per share. It is currently estimated that
this distribution is derived from net realized short-term capital
gains, net realized long-term capital gains and return of capital
or other capital source. The composition of this and subsequent
distributions may vary from quarter to quarter because it may be
materially impacted by future realized gains and losses on
securities. The aggregate of the net unrealized appreciation of
portfolio securities and net realized losses on sale of securities
is $121,604,114, of which $134,975,348 represents net unrealized
appreciation of portfolio securities.
The following table sets forth the estimated amounts of the
current distribution, paid on December 31, 2021, and the cumulative
distributions paid this fiscal year-to-date from the following
sources: net investment income, net realized short-term capital
gains, net realized long-term capital gains and return of capital
or other capital source. The Fund estimates that it has distributed
more than its income and net realized capital gains; therefore, a
portion of your distribution may be a return of capital. A return
of capital may occur, for example, when some or all of the money
that you have invested in the Fund is paid back to you. A return of
capital distribution does not necessarily reflect the Fund’s
investment performance and should not be confused with ‘yield’ or
‘income’. All amounts are expressed per common share.
Current Distribution
Percentage Breakdown of
Current Distribution
Total Cumulative Distributions
for the Fiscal Year to Date1
Percentage Breakdown of the
Total Cumulative Distributions for the Fiscal Year to Date1
Net Investment Income
$0.0000
0%
$0.0000
0%
Net Realized ST Cap Gains
$0.0342
8%
$0.0342
8%
Net Realized LT Cap Gains
$0.2287
55%
$0.2287
55%
Return of Capital or Other Capital
Source
$0.1571
37%
$0.1571
37%
TOTAL (per common share):
$0.4200
100%
$0.4200
100%
The table below includes information relating to the Fund’s
performance based on its NAV for certain periods.
Average annual return at NAV for the
period from October 31, 2016 through October 31, 2021
12.20%
Annualized current distribution rate
expressed as percentage of NAV as of October 31, 2021
8.02%
Cumulative total return at NAV for the
fiscal year, through October 31, 20212
-1.27%
Cumulative fiscal year-to-date
distribution rate expressed as a percentage of NAV as of October
31, 20211
2.00%
You should not draw any conclusions about the Fund’s investment
performance from the amount of this distribution or from the terms
of the Fund’s managed distribution policy.
The amounts and sources of distributions reported in this press
release are only estimates and are not being provided for tax
reporting purposes. The actual amounts and sources of the amounts
for tax reporting purposes will depend upon the Fund’s investment
experience during the remainder of its fiscal year and may be
subject to changes based on tax regulations. The Fund will send you
a Form 1099-DIV for the calendar year that will tell you how to
report these distributions for federal income tax purposes.
Tekla Life Sciences Investors (NYSE: HQL) is a closed-end fund
that invests in companies in the healthcare industry.
Tekla Capital Management LLC, the Fund’s investment adviser, is
a Boston, MA based healthcare-focused investment manager with
approximately $3.6 billion of net assets under management as of
September 30, 2021. Tekla also serves as investment adviser to
Tekla Healthcare Investors (NYSE: HQH), Tekla Healthcare
Opportunities Fund (NYSE: THQ) and Tekla World Healthcare Fund
(NYSE: THW), closed-end funds that invest in companies in the
healthcare and life sciences industries. Information regarding the
Funds and Tekla Capital Management LLC can be found at
www.teklacap.com.
Destra Capital Advisors is the Fund’s marketing and investor
support services agent. Please contact Destra Capital Investments
at HQL@destracapital.com or call (877) 855-3434 if you have any
questions regarding HQL.
1 The Fund’s current fiscal year began on October 1, 2021. 2
Cumulative total return at NAV is the percentage change in the
Fund’s NAV and includes all distributions and assumes the
reinvestment of those distributions for the period of September 30,
2021 through October 31, 2021.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211231005070/en/
Please contact Destra Capital Investments at
HQL@destracapital.com or call (877) 855-3434 if you have any
questions regarding HQL.
abrdn Healthcare Opportu... (NYSE:THQ)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
abrdn Healthcare Opportu... (NYSE:THQ)
Historical Stock Chart
Von Apr 2023 bis Apr 2024